Population Analysis of Escherichia coli Sequence Type 361 and Reduced Cefiderocol Susceptibility, France

Population Analysis of Escherichia coli Sequence Type 361 and Reduced Cefiderocol Susceptibility, France

Cefiderocol resistance is increasingly reported in New Delhi metallo-β-lactamase–producing Enterobacterales. Genomic and phenotypic analysis of Escherichia coli sequence type 361, a primary clone causing carbapenemase spread in France, revealed mutations leading to cefiderocol resistance. Continued...

Full description

Bibliographic Details
Main Authors:	Agnès B. Jousset, Laura Bouabdallah, Aurélien Birer, Isabelle Rosinski-Chupin, Jean-François Mariet, Saoussen Oueslati, Cécile Emeraud, Delphine Girlich, Philippe Glaser, Thierry Naas, Rémy A. Bonnin, Laurent Dortet
Format:	Article
Language:	English
Published:	Centers for Disease Control and Prevention 2023-09-01
Series:	Emerging Infectious Diseases
Subjects:	Escherichia coli bacteria antimicrobial resistance enteric infections food safety carbapenemase
Online Access:	https://wwwnc.cdc.gov/eid/article/29/9/23-0390_article

Similar Items

Polyclonal Dissemination of OXA-232 Carbapenemase–Producing Klebsiella pneumoniae, France, 2013–2021
by: Cecile Emeraud, et al.
Published: (2022-11-01)

Emergence and Polyclonal Dissemination of OXA-244–Producing Escherichia coli, France
by: Cecile Emeraud, et al.
Published: (2021-04-01)

Genetics of Acquired Antibiotic Resistance Genes in Proteus spp.
by: Delphine Girlich, et al.
Published: (2020-02-01)

Undetectable Production of the VIM-1 Carbapenemase in an Atlantibacter hermannii Clinical Isolate
by: Delphine Girlich, et al.
Published: (2021-12-01)

Emergence of New Non–Clonal Group 258 High-Risk Clones among Klebsiella pneumoniae Carbapenemase–Producing K. pneumoniae Isolates, France
by: Rémy A. Bonnin, et al.
Published: (2020-06-01)

Transcriptional Landscape of a blaKPC-2 Plasmid and Response to Imipenem Exposure in Escherichia coli TOP10
by: Agnès B. Jousset, et al.
Published: (2018-12-01)

Genetic Diversity, Biochemical Properties, and Detection Methods of Minor Carbapenemases in Enterobacterales
by: Rémy A. Bonnin, et al.
Published: (2021-01-01)

Genomic characterization of an NDM-9-producing Acinetobacter baumannii clinical isolate and role of Glu152Lys substitution in the enhanced cefiderocol hydrolysis of NDM-9
by: Susie Gaillot, et al.
Published: (2023-08-01)

The emergence of carbapenemase-producing Enterobacterales in hospitals: a major challenge for a debilitated healthcare system in Lebanon
by: Dina Daaboul, et al.
Published: (2023-11-01)

Nationwide molecular epidemiology of carbapenemase-producing Citrobacter spp. in France in 2019 and 2020
by: Laura Biez, et al.
Published: (2023-12-01)

In Vitro Activity of Imipenem-Relebactam, Meropenem-Vaborbactam, Ceftazidime-Avibactam and Comparators on Carbapenem-Resistant Non-Carbapenemase-Producing Enterobacterales
by: Rémy A. Bonnin, et al.
Published: (2023-01-01)

Evaluation of the EasyScreen™ ESBL/CPO Detection Kit for the Detection of ß-Lactam Resistance Genes
by: Camille Gonzalez, et al.
Published: (2022-09-01)

Uncommon close genetic environment responsible for weak expression of blaNDM-1 in Klebsiella pneumoniae of ST147
by: Delphine Girlich, et al.
Published: (2023-03-01)

Specificities and Commonalities of Carbapenemase-Producing Escherichia coli Isolated in France from 2012 to 2015
by: Rafael Patiño-Navarrete, et al.
Published: (2022-02-01)

Prevalence and Molecular Mechanisms of Carbapenem Resistance among Gram-Negative Bacilli in Three Hospitals of Northern Lebanon
by: Mariam Rima, et al.
Published: (2022-09-01)

Multidrug-resistant Enterobacterales responsible for septicaemia in a neonatal intensive care unit in Morocco
by: Patricia Perez-Palacios, et al.
Published: (2023-06-01)

Cefiderocol, a Siderophore Cephalosporin, as a Treatment Option for Infections Caused by Carbapenem-Resistant Enterobacterales
by: Keith S. Kaye, et al.
Published: (2023-02-01)

In vitro Activity of Cefiderocol and Comparators against Carbapenem-Resistant Gram-Negative Pathogens from France and Belgium
by: Saoussen Oueslati, et al.
Published: (2022-10-01)

To Be or Not to Be an OXA-48 Carbapenemase
by: Laura Dabos, et al.
Published: (2022-01-01)

Occurrence and Diversity of CTX-M-Producing Escherichia coli From the Seine River
by: Delphine Girlich, et al.
Published: (2020-12-01)

Carbapenemases from the Laboratory to the Clinic in Gram-Negative Enteric Bacteria
by: Sinem BUDAK, et al.
Published: (2012-12-01)

Reduce susceptibility to cefiderocol in gram negative bacteria in children: Is hope already lost before it’s even arrived?
by: Chiara Russo, et al.
Published: (2024-04-01)

In Vitro Activity of Two Novel Antimicrobial Compounds on MDR-Resistant Clinical Isolates
by: Mariam Rima, et al.
Published: (2023-07-01)

Antibiotic Susceptibility Profiles of Bacterial Isolates Recovered from Abscesses in Cattle and Sheep at a Slaughterhouse in Algeria
by: Chahrazed Yousfi, et al.
Published: (2024-03-01)

Evaluation of ceftolozane-tazobactam susceptibility on a French nationwide collection of Enterobacterales
by: Agnès B. Jousset, et al.
Published: (2023-03-01)

Attributes of Carbapenemase Encoding Conjugative Plasmid pNDM-SAL from an Extensively Drug-resistant Salmonella enterica Serovar Senftenberg
by: Anirban eSarkar, et al.
Published: (2015-09-01)

Beta-lactamase database (BLDB) – structure and function
by: Thierry Naas, et al.
Published: (2017-01-01)

Diversity of mucoid to non-mucoid switch among carbapenemase-producing Klebsiella pneumoniae
by: Adriana Chiarelli, et al.
Published: (2020-10-01)

Rapid Detection of VanA/B-Producing Vancomycin-Resistant Enterococci Using Lateral Flow Immunoassay
by: Saoussen Oueslati, et al.
Published: (2021-09-01)

Retrospective and prospective evaluation of the Carbapenem inactivation method for the detection of carbapenemase-producing Enterobacteriaceae.
by: Lauraine Gauthier, et al.
Published: (2017-01-01)

Usefulness of Xpert® Carba-R on enrichment broth for the early detection of carbapenemase-producing Enterobacterales
by: Delphine Girlich, et al.
Published: (2021-11-01)

Genotypic Evolution of Klebsiella pneumoniae Sequence Type 512 during Ceftazidime/Avibactam, Meropenem/Vaborbactam, and Cefiderocol Treatment, Italy
by: Gabriele Arcari, et al.
Published: (2023-11-01)

Susceptibility Testing Is Key for the Success of Cefiderocol Treatment: A Retrospective Cohort Study
by: Alexandre Bleibtreu, et al.
Published: (2021-01-01)

A single Proteus mirabilis lineage from human and animal sources: a hidden reservoir of OXA-23 or OXA-58 carbapenemases in Enterobacterales
by: Rémy A. Bonnin, et al.
Published: (2020-06-01)

Comment on Mitteregger et al. A Variant Carbapenem Inactivation Method (CIM) for <i>Acinetobacter baumannii</i> Group with Shortened Time-to-Result: rCIM-A. <i>Pathogens</i> 2022, <i>11</i>, 482
by: Andrei-Alexandru Muntean, et al.
Published: (2022-07-01)

In Vitro Activity of Cefiderocol against Clinical Gram-Negative Isolates Originating from Germany in 2016/17
by: Esther Wohlfarth, et al.
Published: (2023-05-01)

Compassionate Use of Cefiderocol to Treat a Case of Prosthetic Joint Infection Due to Extensively Drug-Resistant <i>Enterobacter hormaechei</i>
by: Soline Siméon, et al.
Published: (2020-08-01)

Cefiderocol against Multi-Drug and Extensively Drug-Resistant <i>Escherichia coli</i>: An In Vitro Study in Poland
by: Patrycja Zalas-Więcek, et al.
Published: (2022-12-01)

Comparison of Broth Microdilution, Disk Diffusion and Strip Test Methods for Cefiderocol Antimicrobial Susceptibility Testing on KPC-Producing <i>Klebsiella pneumoniae</i>
by: Federica Bovo, et al.
Published: (2023-03-01)

Outbreak of CTX-M-15 Extended-Spectrum β-Lactamase-Producing <i>Klebsiella pneumoniae</i> ST394 in a French Intensive Care Unit Dedicated to COVID-19
by: Cécile Emeraud, et al.
Published: (2021-11-01)